Test Price
2,600 AED✅ Home Collection Available
Next‑Generation Sequencing (NGS) for Dementia Genetic Testing in UAE | 2600 AED | 2026 DHA Guidelines
تحليل الجيل التالي لتسلسل الخرف (NGS) في الإمارات | 2600 درهم | معتمد من هيئة الصحة بدبي
Executive Clinical Summary
ملخص تنفيذي: يقدم تحليل الجيل التالي للخرف في مختبرنا المعتمد دولياً (ISO 9001:2015) حساسية تشخيصية بنسبة 99.9% وفقاً لإرشادات هيئة الصحة بدبي لعام 2026. تشمل الخدمة سحباً منزلياً مبرداً بسلسلة تبريد معقمة (VIP Mobile Phlebotomy) مع استشارة هاتفية لتفسير النتائج، وتغطية تأمينية مباشرة عبر واتساب.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity (NGS + Sanger confirmation) via ISO‑accredited processing.
- Premium Logistics: Hospital‑grade home collection with ISO‑certified cold‑chain (2–8°C) and VIP mobile phlebotomy.
- Clinical Guidance: Telephonic post‑test clinical counselling by a DHA‑licensed neurologist for result interpretation.
- Insurance: Direct billing verification via WhatsApp at +971 54 548 8731.
Test Overview
This next‑generation sequencing dementia panel screens for pathogenic variants in genes associated with Alzheimer disease, frontotemporal dementia, Lewy body dementia, and other neurodegenerative disorders. (يُعد هذا التحليل أدق فحص جيني للخرف في الإمارات، حيث يجمع بين تقنية NGS وسلسلة Sanger لتأكيد الطفرات المسببة للمرض.) The report is returned with DHA‑compliant interpretation and actionable recommendations for clinicians.
| Feature | Our Test (NGS Dementia Panel) | Closest Alternative (Targeted Genotyping) |
|---|---|---|
| Diagnostic Precision | 99.9% sensitivity, full gene coverage + CNV analysis | ~85% sensitivity, limited variant types |
| Methodology | NGS (Illumina) with Sanger confirmatory sequencing | Array‑based genotyping or single‑gene Sanger |
| Turnaround Time | 40 working days (meticulous bioinformatics) | 20–30 working days (limited analysis) |
Physician Insight & Safety Protocol
“As a neurologist, I rely on this comprehensive NGS panel to uncover rare genetic etiologies behind early‑onset dementia. The findings must always be correlated with clinical and imaging data; a positive result guides tailored surveillance but does not replace specialist follow‑up. I urge patients to discuss results with a qualified clinician before making any health decisions.”
— Dr. PRABHAKAR REDDY, DHA License: 61713011
Medication Safety Warning
Do not discontinue or modify any prescribed medication (e.g., cholinesterase inhibitors, memantine) without consulting your treating physician. Genetic results may inform long‑term strategy but are never a substitute for ongoing clinical management.
Exclusion Criteria & ER Red Flags
- Exclusion: Prior bone marrow transplant or history of allogeneic transfusion within the last 7 days (may cause chimerism).
- Exclusion: Inability to provide mandatory signed Whole Exome Sequencing Consent Form (Form 37).
- Red Flag: Sudden onset of severe headache, confusion, or focal neurological deficits during the waiting period — seek emergency care; genetic testing does not rule out acute intracranial events.
Frequently Asked Questions
Q: How does this test differ from standard genetic screening for Alzheimer’s?
This NGS panel sequences all known dementia‑associated genes with copy number variant detection, delivering definitive diagnostic accuracy exceeding routine APOE genotyping alone. (يُستخدم هذا الفحص الموسع للكشف عن الطفرات النادرة في جينات مثل APP وPSEN1 وGRN وMAPT، مما يجعله أداة تشخيصية شاملة.)
Q: Is home blood collection safe and how is the sample kept stable?
Certified phlebotomists use sterile venipuncture and immediately place EDTA tubes in validated 2–8°C transport boxes, preserving DNA integrity without freezing. (يضمن نظام التبريد المعتمد من ISO استقرار العينة لمدة تصل إلى 72 ساعة أثناء النقل إلى المختبر.)
Q: Will my insurance cover this test and how do I confirm?
Our team validates coverage directly with your insurer via WhatsApp, and we will notify you of any co‑payment before sample collection. (يتم التحقق من التغطية التأمينية مباشرة عبر واتساب مع بطاقة التأمين الخاصة بك، وسيتم إبلاغك بأي مبلغ مستحق قبل سحب العينة.)
Sample Collection & Pre‑ Requirements
Sample: Submit 10 mL (5 mL min.) whole blood in 2 Lavender Top (EDTA) tubes. Ship refrigerated (2–8°C). DO NOT FREEZE. Duly filled Whole Exome Sequencing Consent Form (Form 37) is mandatory.
TAT: Sample accepted daily by 9 AM; report delivered within 40 working days.
Support: Home collection available 8 AM – 11 PM daily. WhatsApp +971 54 548 8731.
Compliant with UAE Federal Decree‑Law No. 41 of 2024 (Art. 87), CDS Law 2026 (Minors), and UAE PDPL (Data Privacy).
ISO 9001:2015 Certified – Cert: INT/EGQ/2509DA/3139. Facility License: 9834453.
Clinical review by Dr. PRABHAKAR REDDY, DHA 61713011. All genetic testing requires informed consent.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians